血液バンキング市場：タイプ、製品、エンドユーザー別-2025-2030年の世界予測

血液バンキング市場は、2023年に150億1,000万米ドルと評価され、2024年には168億9,000万米ドルに達すると予測され、CAGR 12.99％で成長し、2030年には353億1,000万米ドルになると予測されています。

ヘルスケアサービスに不可欠な要素である血液バンキング市場には、ヒト血液および血液成分の収集、処理、検査、保管、流通が含まれます。血液バンキングの必要性は、輸血による人命救助、様々な病状、緊急事態の治療、手術のサポートなどの重要な役割から生じています。重要な用途としては、血液疾患の管理、がん治療のサポート、外傷治療の補助などがあります。最終用途分野には、病院、診療所、血液銀行、外来手術センター、研究所などが含まれます。市場成長は、輸血を必要とする慢性疾患の有病率の上昇、外科手術の増加、安全で利用しやすい血液供給のための政府の取り組み、血液保存・保管技術の進歩などの要因に影響されます。自動採血システム、病原体削減技術、血液検査方法の改善などの技術革新は、大きな機会を提供します。研究開発強化のためのパートナーシップと協力を重視することで、利害関係者はこれらの市場ギャップに効果的に対処することができます。しかし、厳しい規制政策、血液感染リスク、高い運用コスト、採血・保存方法の標準化不足などの課題もあります。さらに、発展途上地域における認知度の低さも大きなハードルとなっています。成長機会を活用するために、利害関係者は移動採血技術への投資を優先し、ドナー募集戦略を拡大すべきです。コールドチェーン・ロジスティクスと血液在庫管理のための予測分析における革新は、業界に革命をもたらす可能性があります。市場の性質はダイナミックであり、一貫した需要とイノベーションに牽引され、技術の進歩や規制の変更に常に適応する必要があります。代用人工血液や人工血液の最先端研究に注力することで、企業は進化するニーズに対応し、供給リスクを軽減することができます。さらに、献血とその救命効果に関する一般市民の認識と教育を強化することで、市場基盤を強化し、拡大するヘルスケア需要に対応する安定した血液サプライチェーンを確保することができます。

市場力学：急速に進化する血液バンキング市場の主要市場インサイトを公開

血液バンキング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 血液疾患の高い有病率と事故事例の増加
  • 輸血感染症や手術の増加に伴う血液媒介性疾患の負担増
  • 献血キャンプの実施など、政府および非政府の取り組み
  • HIVやB型肝炎のような輸血感染症の高い有病率
• 市場抑制要因
  • 維持費と血液処理装置の高コスト
• 市場機会
  • 高度な機器に対する需要の増加
  • 積極的に変化する償還シナリオ
  • 献血と安全な輸血に対する意識の高まり
• 市場の課題
  • 厳しい規則と規制シナリオ

ポーターの5つの力：血液バンキング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血液バンキング市場における外部からの影響の把握

外部マクロ環境要因は、血液バンキング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血液バンキング市場における競合情勢の把握

血液バンキング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血液バンキング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血液バンキング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血液バンキング市場における成功への道筋を描く

血液バンキング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 血液疾患の有病率の高さと事故発生率の増加
    • 血液媒介疾患の負担が増大し、輸血による感染症や手術の増加も相まって
    • 献血キャンプの実施など政府および非政府による取り組み
    • HIVやB型肝炎などの輸血感染性感染症の蔓延率が高い
  • 抑制要因
    • メンテナンスと血液処理装置のコストが高い
  • 機会
    • 高度な機器に対する需要の増加
    • 償還シナリオを前向きに変える
    • 献血と安全な輸血に関する意識の高まり
  • 課題
    • 厳格な規則と規制のシナリオ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血液バンキング市場：タイプ別

• プライベート
• 公共

第7章 血液バンキング市場：製品別

• プラズマ
• 血小板
• 赤血球
• 白血球
• 全血

第8章 血液バンキング市場：エンドユーザー別

• 外来手術センター
• 診断センター
• 病院

第9章 南北アメリカの血液バンキング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の血液バンキング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの血液バンキング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AMAG Pharmaceuticals, Inc.
• Americord Registry LLC
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc
• bioMerieux SA
• Cardinal Health, Inc
• China Biologic Products, Inc.
• Cordlife Group Limited
• F. Hoffmann-La Roche Ltd
• Fresenius Kabi AG
• Immucor, Inc.
• Johnson & Johnson
• Krew Instruments Pvt Ltd
• Macopharma SA
• Narang Medical Limited
• Remi Elektrotechnik Limited
• Terumo BCT, Inc.
• Thermo Fisher Scientific Inc.
• ViaCord LLC

LIST OF FIGURES

• FIGURE 1. BLOOD BANKING MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD BANKING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD BANKING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD BANKING MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Banking Market was valued at USD 15.01 billion in 2023, expected to reach USD 16.89 billion in 2024, and is projected to grow at a CAGR of 12.99%, to USD 35.31 billion by 2030.

The blood banking market, an essential component of healthcare services, encompasses the collection, processing, testing, storage, and distribution of human blood and blood components. The necessity of blood banking arises from its critical role in saving lives through transfusions, treating various medical conditions, emergencies, and supporting surgeries. Vital applications include managing blood disorders, supporting cancer treatments, and aiding trauma care. The end-use sectors encompass hospitals, clinics, blood banks, ambulatory surgical centers, and research laboratories. Market growth is influenced by factors such as the rising prevalence of chronic diseases requiring blood transfusions, increased surgical procedures, government initiatives for safe and accessible blood supply, and advancements in blood storage and preservation techniques. Technological innovations, like automated blood collection systems, pathogen reduction technologies, and improved blood testing methods, provide significant opportunities. Emphasizing partnerships and collaborations for enhanced R&D will enable stakeholders to address these market gaps effectively. However, challenges include stringent regulatory policies, the risk of bloodborne infections, high operational costs, and a lack of standardization in blood collection and storage practices. Additionally, limited awareness in developing regions poses a significant hurdle. To capitalize on growth opportunities, stakeholders should prioritize investments in mobile blood collection technologies and expand donor recruitment strategies. Innovations in cold chain logistics and predictive analytics for blood inventory management can revolutionize the industry. The market's nature is dynamic, driven by consistent demand and innovations, requiring constant adaptation to technological advancements and regulatory changes. By focusing on cutting-edge research in synthetic blood substitutes and artificial blood, businesses can cater to evolving needs and mitigate supply risks. Additionally, enhancing public awareness and education about blood donation and its life-saving benefits can strengthen market foundations and ensure a stable blood supply chain to meet expanding healthcare demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Banking Market

The Blood Banking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High prevalence of hematologic diseases and rising incidences of accidental cases
  • Growing burden of blood-borne diseases coupled with the increasing prevalence of transfusion transmissible infection and surgeries
  • Government and non-government initiatives such as conduction of blood donation camps
  • High prevalence of transfusion transmissible infections such as HIV and hepatitis B
• Market Restraints
  • High cost of maintenance and blood processing equipment
• Market Opportunities
  • Increasing demand for advanced instruments
  • Positively changing reimbursement scenarios
  • Growing awareness about blood donation and safe blood transfusion
• Market Challenges
  • Stringent rules and regulations scenario

Porter's Five Forces: A Strategic Tool for Navigating the Blood Banking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Banking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Banking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Banking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Banking Market

A detailed market share analysis in the Blood Banking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Banking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Banking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Banking Market

A strategic analysis of the Blood Banking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Banking Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMAG Pharmaceuticals, Inc., Americord Registry LLC, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc, bioMerieux SA, Cardinal Health, Inc, China Biologic Products, Inc., Cordlife Group Limited, F. Hoffmann-La Roche Ltd, Fresenius Kabi AG, Immucor, Inc., Johnson & Johnson, Krew Instruments Pvt Ltd, Macopharma SA, Narang Medical Limited, Remi Elektrotechnik Limited, Terumo BCT, Inc., Thermo Fisher Scientific Inc., and ViaCord LLC.

Market Segmentation & Coverage

This research report categorizes the Blood Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Private and Public.
• Based on Product, market is studied across Plasma, Platelets, Red Blood Cells, White Blood Cells, and Whole Blood.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of hematologic diseases and rising incidences of accidental cases
    • 5.1.1.2. Growing burden of blood-borne diseases coupled with the increasing prevalence of transfusion transmissible infection and surgeries
    • 5.1.1.3. Government and non-government initiatives such as conduction of blood donation camps
    • 5.1.1.4. High prevalence of transfusion transmissible infections such as HIV and hepatitis B
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of maintenance and blood processing equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing demand for advanced instruments
    • 5.1.3.2. Positively changing reimbursement scenarios
    • 5.1.3.3. Growing awareness about blood donation and safe blood transfusion
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent rules and regulations scenario
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Banking Market, by Type

• 6.1. Introduction
• 6.2. Private
• 6.3. Public

7. Blood Banking Market, by Product

• 7.1. Introduction
• 7.2. Plasma
• 7.3. Platelets
• 7.4. Red Blood Cells
• 7.5. White Blood Cells
• 7.6. Whole Blood

8. Blood Banking Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Diagnostic Centers
• 8.4. Hospitals

9. Americas Blood Banking Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Blood Banking Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Blood Banking Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AMAG Pharmaceuticals, Inc.
• 3. Americord Registry LLC
• 4. Beckman Coulter, Inc.
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories Inc
• 7. bioMerieux SA
• 8. Cardinal Health, Inc
• 9. China Biologic Products, Inc.
• 10. Cordlife Group Limited
• 11. F. Hoffmann-La Roche Ltd
• 12. Fresenius Kabi AG
• 13. Immucor, Inc.
• 14. Johnson & Johnson
• 15. Krew Instruments Pvt Ltd
• 16. Macopharma SA
• 17. Narang Medical Limited
• 18. Remi Elektrotechnik Limited
• 19. Terumo BCT, Inc.
• 20. Thermo Fisher Scientific Inc.
• 21. ViaCord LLC